The New York Times – Business:
In rare cases, an immune reaction has led to antibodies that caused a serious clotting disorder. But public health experts maintain the vaccine’s benefits far outweigh the risks for most people.
Author: RSS Feed
This post first appeared in The New York Times – Business. Read the original article.